Sanofi-Synthelabo Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 15, 2004, by Sanofi-Synthelabo (a French foreign private issuer), serves to notify the SEC of the publication of its annual financial results. The filing references the consolidated and parent company financial statements, auditors' reports, and management report for the fiscal year ended December 31, 2003. These documents were published in the French official gazette (BALO) on March 12, 2004, and made available on the company's website.
Key Financial Metrics
The provided filing text acts as a cover sheet and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity for the year ended December 31, 2003. These figures are contained within the referenced exhibits (Exhibit 99.2 and 99.3) which are not included in the input text.
Material Changes
The filing text does not provide a comparison of financial performance versus the prior comparable period. No specific material changes in financial position or results of operations are detailed in this summary document.
Guidance, Outlook, and Risks
This specific Form 6-K text does not include management commentary, future guidance, risk factors, contingencies, or unusual items. Such information is expected to be found in the Management Report (Exhibit 99.4) and the Press Release (Exhibit 99.1) referenced in the exhibit list.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the Consolidated Financial Statements (Exhibit 99.2).
- Review the Management Report (Exhibit 99.4) for strategic outlook and risk disclosures.
- Confirm the auditors' opinions in the reports on consolidated and parent company statements (Exhibits 99.5 and 99.6).
- Check the Press Release (Exhibit 99.1) for high-level highlights and market reaction.